1/18
Vocabulary flashcards covering the etiology, classification, diagnostic methods, Doppler parameters, and clinical management strategies for intrauterine growth restriction (IUGR) and small for gestational age (SGA) fetuses.
Small for gestational age (SGA)
A heterogeneous clinical classification referring to fetuses or neonates whose measurements fall below expected percentiles (commonly defined as <10th centile, with <3rd to 5th centile carrying the greatest risk of adverse perinatal outcomes), encompassing constitutionally small fetuses, chromosomal or structural defects, intrauterine infections, and true growth restriction.
Intrauterine growth restriction (IUGR)
A pathological condition and subset of SGA resulting from an inadequacy in the supply of nutrients and/or oxygen to the fetus through the uteroplacental unit, preventing the fetus from reaching its genetically determined growth potential and increasing risks of perinatal morbidity, mortality, and adult degenerative diseases.
Constitutionally small fetus
A healthy fetus of small stature that accounts for 80–85% of all SGA fetuses in accurately dated pregnancies, exhibiting a symmetric growth rate parallel to normal curves, normal anatomical structures, normal amniotic fluid volume, and normal umbilical artery Doppler findings.
Customised antenatal growth charts
Growth assessment curves adjusting for physiological maternal variables—specifically maternal height, booking weight, parity, and ethnic group—that plot weeks of gestation on the x-axis against symphysis fundal height or ultrasound-derived fetal weight on the y-axis to reduce false-positive and false-negative misclassifications of growth disorders.
Early onset SGA (Symmetric growth restriction)
Growth restriction presenting in the early stages of pregnancy (cellular hyperplasia phase, before 16 to 32 weeks), resulting in a proportionate reduction across all fetal organs; primary etiologies include severe maternal vascular disease, chromosomal or structural anomalies, and congenital infections.
Late onset SGA (Asymmetric growth restriction)
Growth restriction presenting after 32 weeks of gestation during the cellular hypertrophy phase, primarily caused by uteroplacental dysfunction and characterized by a disproportionate reduction in abdominal circumference relative to head circumference and length.
Brain-sparing effect
A compensatory hemodynamic adaptation in late-onset fetal hypoxaemia whereby blood flow is redistributed to vital organs (the brain, heart, and placenta) and away from the viscera, maintaining head circumference while reducing liver size and subcutaneous abdominal fat.
TORCH infections
A group of congenital fetal infections—notably toxoplasmosis, rubella, cytomegalovirus, varicella, and HIV—that impair early cellular hyperplasia, causing early symmetric growth restriction.
Insulin-like growth factor 1 receptor (IGF-1R) gene mutation
A genetic mutation causing disordered function of IGF-1 receptors, which has been identified as a cause of restricted intrauterine fetal growth and suboptimal postnatal physical development.
Symphysis fundal height (SFH) measurement
A clinical screening procedure where the clinician positions the patient supine with legs extended and bladder empty, palpates the fundus caudally from the xiphisternum, and measures the distance to the upper border of the pubic symphysis using a non-elastic tape laid scale-face-down along the uncorrected uterine axis.
Abdominal circumference (AC)
An ultrasound biometry measurement assessing fetal liver volume and glycogen storage, directly reflecting fetal nutritional status; a value <10th centile on customised charts provides high sensitivity for detecting IUGR, whereas a normal value has a high negative predictive value.
Growth velocity
The rate of anatomical change and fetal weight gain measured over serial ultrasound examinations (typically separated by at least 2 weeks), recognized as the single most sensitive indicator of fetal growth.
Umbilical artery (UA) Doppler
An ultrasound surveillance modality used to assess vascular resistance in the fetoplacental circulation; uteroplacental insufficiency causes reduced diastolic flow and an increased systolic/diastolic flow ratio.
Absent or reversed end-diastolic flow (A/RED)
A severe umbilical artery Doppler abnormality signifying critical downstream vascular resistance; before 34 weeks, it requires maternal admission, antenatal corticosteroids, and intensive monitoring, while at ≥34 weeks or alongside abnormal biophysical profile findings, it indicates expedited delivery.
Pulsatile umbilical venous flow
An advanced hemodynamic abnormality detected via venous Doppler studies indicating severe fetal acidaemia, impending decompensation, and an elevated risk of intellectual impairment and perinatal death.
Amniotic fluid index (AFI)
An ultrasound measurement assessing amniotic fluid volume, where reduced volume or oligohydramnios (AFI<5cm or a single deepest vertical pocket <2cm) is strongly linked to increased perinatal mortality and indicates the need to expedite delivery.
Biophysical profile (BPP)
A composite assessment tool evaluating fetal dynamic activities and cardiotocography; although not recommended for routine low-risk screening, it provides a high negative predictive value in evaluating fetal wellbeing when umbilical artery Doppler flow is abnormal.
Growth Restriction Intervention Trial (GRIT)
A landmark clinical trial concluding that at gestations less than 31 weeks, delivery is best delayed if there is clinical uncertainty regarding intervention, showing that early delivery does not reduce adverse neurological or survival outcomes.
Alpha-fetoprotein (AFP) screening
A biochemical serum marker which, when found to be elevated in the absence of fetal structural anomalies, correlates with a 5–10× increased risk of developing IUGR later in pregnancy.